Park Ridge, NJ, United States of America

Eugene J Trybulski

This inventor holds 16 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: American Cyanamid Company, American Home Products Corporation. Active years: 1990-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eugene J Trybulski. Retrieved from https://idiyas.com/inventor/eugene-j-trybulski-p3t60k5g

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 110(Granted Patents)

Location History:

Bergen, NJ (US) (1990)
Park Ridge, NJ (US) (1990 - 1997)
Princeton Junction, NJ (US) (1999 - 2001)

Company Filing History:

12 out of 3,580

American Cyanamid Company

patents

4 out of 1,567

American Home Products Corporation

patents

Years Active: 1990-2001

Loading Chart...

Areas of Expertise:

Oxotremorine Derivatives

Pharmaceutical Use

Tricyclic Pyridine

Enaminones

Carboxamide Derivatives

Maleimide Derivatives

Thiazole Derivatives

Dibromovinyl Intermediates

Amino-Propynyl Compounds

Benzodiazepines

Diazabicyclo Compounds

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6235900 - Tricyclic pyridine N-oxides vasopressin agonists (2001-05-22),

2. 5932745 - Process for converting propargylic amine-N-oxides to enaminones (1999-08-03),

3. 5880122 - 3-Carboxamide derivatives of 5H-pyrrolo�2,1-c!�1,4!-benzodiazepines (1999-03-09),

4. 5637731 - Substituted oxotremorine derivatives (1997-06-10),

5. 5550257 - Substituted oxotremorine derivatives (1996-08-27),

6. 5478939 - (R,R) and (S,S) 2,5-diazabicyclo [2,2,1]heptane derivatives (1995-12-26),

7. 5451685 - Substituted oxotremorine derivatives (1995-09-19),

8. 5356885 - Substituted oxotremorine derivatives and pharmaceutical use thereof (1994-10-18),

9. 5346910 - Maleimide derivatives of oxotremorine (1994-09-13),

10. 5128483 - Dibromovinyl and acetylene-1-pyrrolidinecarboxylic acid intermediates (1992-07-07),

11. 5089518 - 3- or 4-substituted oxotremorine derivatives and a method of treating (1992-02-18),

12. 5025099 - (3-amino-1-propynyl)methylthiothiophene derivatives (1991-06-18),

13. 5001142 - 1-substituted-2-(3-amino-1-propynyl)pyrrolidine derivatives (1991-03-19),

14. 4990520 - 2-,4- or 5-substituted thiazole derivatives (1991-02-05),

15. 4952600 - 3- or 4-substituted oxotremorine derivatives and a method of treating (1990-08-28),

Title: The Innovative Contributions of Eugene J Trybulski

Introduction

Eugene J Trybulski is a notable inventor based in Park Ridge, NJ, who has made significant contributions to the field of chemistry. With a total of 16 patents to his name, he has demonstrated a strong commitment to innovation and scientific advancement. His work has had a lasting impact on various applications in the industry.

Latest Patents

Among his latest patents, Trybulski has developed compounds known as tricyclic pyridine N-oxides vasopressin agonists. This invention provides compounds of a general formula that can be utilized in various therapeutic applications. Additionally, he has created a process for converting propargylic amine-N-oxides to enaminones. This invention involves the use of a hydroxylic solvent in the preparation of enaminones from the corresponding amine N-oxides or propargylic amines, showcasing his innovative approach to chemical processes.

Career Highlights

Throughout his career, Eugene J Trybulski has worked with prominent companies such as American Cyanamid Company and American Home Products Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development projects.

Collaborations

In his professional journey, Trybulski has collaborated with esteemed colleagues, including Herbert J Brabander and Richard H Kram

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]